November 10, 2026 | AI, HEOR, Market Access, RWE, evidence generation, evidence generation planning platform, evidence planning, evidence strategy, iegp, technology
Genesis Research Group (Genesis) launches Keystone, its modular platform for Integrated Evidence Generation Planning (IEGP), at ISPOR Europe 2026.

Built on Genesis’s extensive experience developing value and evidence strategies and integrated evidence generation plans (IEGPs) for global clients, Keystone enables life sciences organizations to connect value strategy, evidence, evidence gaps, prioritization, tactical planning and execution within a single, governed environment.
Designed to support a living evidence strategy across the product lifecycle, the platform enables organizations to move beyond fragmented plans maintained across slide decks, spreadsheets and disconnected workstreams. Unlike traditional planning tools, it connects evidence, decisions and actions in a single digital workspace, helping teams maintain one product strategy, one evidence agenda and one set of shared priorities. The result is a coordinated, continuously managed process.
“Organizations are under increasing pressure to make evidence planning decisions earlier, coordinate across more functions, and meet evolving global evidence requirements,” said Sarah Alwardt, PhD, Executive Vice President, RWE/HEOR at Genesis Research Group. “Keystone was developed to help teams align around a shared evidence agenda, prioritize the evidence that matters most, and connect evidence needs to actionable plans.”
The launch coincided with Genesis’s presence at ISPOR Europe in Vienna (Booth 211) and HEOR Theater presentation, How Early Is Early Enough? Rethinking Evidence Planning for Today’s Global Access Challenges, presented by Priti Jhingran, PhD, Vice President, Head of HEOR Strategy & Partnerships. The session explored how organizations can move from evidence planning as a periodic exercise to a continuous, structured process that supports cross-functional alignment, transparent decision-making and evidence strategies that remain responsive to evolving market access requirements.
Genesis Research Group, an official ISPOR corporate partner, contributed to 11 poster presentations in this year’s scientific program, spanning artificial intelligence, health economics, market access, evidence synthesis and patient-centered outcomes research, with one poster recognized among the top 5% of research submissions to the event.
To schedule a meeting or learn more about Keystone, visit Genesisrg.com.
This content was provided by Genesis Research Group